I was thinking about this also. If we actually get an approval, we won’t be able to scratch the surface in either of these markets (Brazil or India).
I suppose that will be a good problem to have. The key point is that we are now in the markets that we need to be in. Forget the U.S.
(7)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-